Article
Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Cancer research - 1 Jul 2007
Paulson K Eric, Rieger-Christ Kimberly, McDevitt Michael A, Kuperwasser Charlotte, Kim Jiyoung, Unanue Vincent E, Zhang Xiaowei, Hu Maowen, Ruthazer Robin, Berasi Stephen P, Huang Chun-Yin, Giri Dilip, Kaufman Seth, Dugan John M, Blum Joanne, Netto Georges, Wazer David E, Summerhayes Ian C, Yee Amy S
Abstract excerpt
Invasive breast cancer has a high risk of recurrence to incurable disease and needs improved prognostic and therapeutic tools. Our work combines clinical and molecular analyses to show that the transcriptional repressor HBP1 may be a new target for invasive breast cancer. Previous work indicated that HBP1 regulated proliferation and senescence and inhibited Wnt signaling. Two of these functions have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
